We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
P5‐47: Safety and efficacy of remdesivir, baricitinib and high‐dose steroid combination therapy in patients hospitalized with COVID‐19.
- Abstract
B Conclusions b : This study revealed the safety profile of three-drug combination therapy of high-dose steroids, REM, and BAR in COVID-19 patients. B Methods b : We reviewed the medical records of all consecutive patients who underwent three-drug combination therapy of high-dose steroid (80 mg of methylprednisolone or more per day), REM, and BAR in our institution from January to May 2021. P5-47: Safety and efficacy of remdesivir, baricitinib and high-dose steroid combination therapy in patients hospitalized with COVID-19.
- Subjects
COVID-19; STEROID drugs; BARICITINIB; REMDESIVIR
- Publication
Respirology, 2021, Vol 26, p175
- ISSN
1323-7799
- Publication type
Article
- DOI
10.1111/resp.14150_254